Eli Lilly Offers Access To Zepbound via Amazon
March 14, 2024 The U.S. pharmaceutical giant Eli Lilly is partnering with Amazon to help distribute its prescription drugs, notably its new weight loss treatment
U.S. Weight Loss Market Worth $90 Billion, Boosted by Diet Drugs
March 4, 2024 U.S. Weight Loss Market Now Worth $90 Billion, Obesity Drug Sales Soar March 4, 2024 Marketdata LLC has just published a new
Weight Watchers Reports Q4 and 2023 Results
Feb. 28, 2024 WW reported its results for Q4 2023 and the full year today. WW reported results in line with analysts’ expectations in Q4
Medifast Reports Q4 and Full Year 2023 Results
Feb. 20, 2024 Medifast reported full-year and Q4 results on February 20, 2023. 2023 revenues came in at $1.07 billion. The company employed 41,100 active
Bariatric Surgery Volume Sees Big Increase In 2021
January 30, 2024 Based on the latest data from the ASMBS (American Society for Metabolic and Bariatric Surgery), the number of surgeries performed jumped by
More Obesity Drugs In The Pipeline
January 20, 2024 Novo Nordisk and Eli Lilly aren’t the only drug companies active in the prescription diet drugs space. Viking Therapeutics has a dual
Ozempic Boom Is Hurting Weight Loss Coaches
Jan. 11, 2024 The pandemic had significant effects on the way commercial weight loss companies operate, along with the explosive demand for GLP-1 obesity drugs
Eli Lilly Offers Weight Loss Drug Direct to Consumers
January 5, 2023 Eli Lilly and Company launched a website, lillydirect.com, to enable people to directly order from the drug maker including its weight-loss medicine